Skip to main content

News & Announcements


Longevity gene may boost brain power


Researchers find association between abnormal tau and damaged brain cell DNA


NIH-supported clinical trial finds antidepressant reduces Alzheimer's agitation


NIH, industry and non-profits join forces to speed validation of disease targets


Rare genetic variants may double risk for Alzheimer's disease


NIH deposits first batch of genomic data for Alzheimer's disease


NIH-supported study identifies 11 new Alzheimer's disease risk genes


NIH funding boosts new Alzheimer's research on prevention, novel drug targets


Amylin deposits in the brain may link dementia and diabetes


Falls may be sign of future Alzheimer's disease, cognitive decline


Novel NIH initiative enables testing of existing compound as Alzheimer's treatment


Biomarkers can predict risk for Alzheimer's several years before symptoms appear


Suppressing protein may stem Alzheimer's disease process


Gene variant linked to higher risk of Alzheimer's in African Americans


NIH-supported study finds U.S. dementia care costs as high as $215 billion in 2010


Analysis finds gene variants associated with Alzheimer's amyloid deposition


NIH-supported Alzheimer's studies to focus on innovative treatments


NIH-supported international teams identify rare Alzheimer's disease risk gene variant


Genetic variation linked to age-related hearing loss


New database aims to capture international Alzheimer's disease research efforts


Risk gene for Alzheimer's disease associated with lower brain amyloid


Investigators create “brain map” of key epigenetic processes


CADRO: Common Alzheimer's Disease Research Ontology


Cancer drug bexarotene reverses Alzheimer's deficits in mice


Protein involved in brain-wave maintenance linked to Alzheimer's-related cognitive dysfunction